| 000 | 01429 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515205402.0 | ||
| 264 | 0 | _c20100824 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a1873-1686 | ||
| 024 | 7 |
_a10.1016/j.regpep.2010.01.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKidd, M | |
| 245 | 0 | 0 |
_aThe CCK(2) receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development. _h[electronic resource] |
| 260 |
_bRegulatory peptides _cJun 2010 |
||
| 300 |
_a52-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzodiazepinones _xpharmacology |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHyperplasia _xprevention & control |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMurinae |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xpharmacology |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aReceptor, Cholecystokinin B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSerotonin _xmetabolism |
| 650 | 0 | 4 |
_aStomach Neoplasms _xpathology |
| 700 | 1 | _aSiddique, Z-L | |
| 700 | 1 | _aDrozdov, I | |
| 700 | 1 | _aGustafsson, B I | |
| 700 | 1 | _aCamp, R L | |
| 700 | 1 | _aBlack, J W | |
| 700 | 1 | _aBoyce, M | |
| 700 | 1 | _aModlin, I M | |
| 773 | 0 |
_tRegulatory peptides _gvol. 162 _gno. 1-3 _gp. 52-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.regpep.2010.01.009 _zAvailable from publisher's website |
| 999 |
_c19515780 _d19515780 |
||